To confirm that this interaction is dependent upon the activation status of endogenous KRAS, we used the aforementioned RBD polypeptide to affinity capture endogenous GTP-bound RAS from lysates isolated from the KRAS mutation-positive human pancreatic adenocarcinoma cell line AsPC-1. The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.